跳至主要内容
临床试验/JPRN-UMIN000032280
JPRN-UMIN000032280已完成未知

An exploratory study on the usefulness of topical benzoxyl peroxide for prolonged acneiform eruption by EGFR inhibitors - Study on the usefulness of topical benzoyl peroxide for acneiform eruption by EGFR inhibitors

Tohoku University Hospital0 个研究点目标入组 20 人开始时间: 2018年4月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 79years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Oral tetracycle (MINO or DOXY) has been started within 4 weeks for the treatment of acneiform eruption. (2)Oral steroids are administrated for the treatment of acneiform eruption. (3)Patient has skin lesion of skin metastatic lesions, burns, frostbite, trauma, scars and/or other lesions to be difficult to evaluate skin symptoms on the test area. (4)Patient has erosions, wounds, etc. that are problematic in applying benzoyl peroxide: BPO gel to the test area. (5)Patient has a history of hypersensitivity to BPO. (6)Pregnant women, women who has possibility of pregnant, woman within 28 days after childbirth, or woman who in breastfeeding. (7)Patient who is considered to have difficulty participating in research by merging psychosis or psychiatric symptoms. (8)Patient who researchers deem that research participation is inappropriate.

研究者

相似试验